Zevra Therapeutics annual gross profit
2018
2019
2021
2022
2023
2024
2025
Zevra Therapeutics Gross Profit Growth & History (ZVRA)
Zevra Therapeutics's gross profit was $90.0M for fiscal 2025.
View full Zevra Therapeutics company overviewZevra Therapeutics annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $90.0M | $73.8M | +455.65% |
| 2024 | 2024-12-31 | $16.2M | −$8.3M | −33.94% |
| 2023 | 2023-12-31 | $24.5M | $14.6M | +146.66% |
| 2022 | 2022-12-31 | $9.9M | −$16.7M | −62.62% |
| 2021 | 2021-12-31 | $26.6M | — | — |
| 2019 | 2019-12-31 | $2.8M | $2.8M | — |
| 2018 | 2018-12-31 | $0 | — | — |
Zevra Therapeutics quarterly gross profit
Q3.19
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $38.1M | $24.6M | +182.46% |
| Q1 2026 | 2026-03-31 | $34.3M | $15.3M | +80.12% |
| Q4 2025 | 2025-12-31 | $32.6M | $21.9M | +205.38% |
| Q3 2025 | 2025-09-30 | $24.8M | $23.4M | +1683.41% |
| Q2 2025 | 2025-06-30 | $13.5M | $12.6M | +1441.32% |
| Q1 2025 | 2025-03-31 | $19.1M | $15.8M | +486.34% |
| Q4 2024 | 2024-12-31 | $10.7M | −$244,000 | −2.23% |
| Q3 2024 | 2024-09-30 | $1.4M | −$1.4M | −49.40% |
| Q2 2024 | 2024-06-30 | $876,000 | −$6.9M | −88.76% |
| Q1 2024 | 2024-03-31 | $3.3M | $199,000 | +6.52% |
| Q4 2023 | 2023-12-31 | $10.9M | $8.9M | +446.05% |
| Q3 2023 | 2023-09-30 | $2.8M | $18,000 | +0.66% |
| Q2 2023 | 2023-06-30 | $7.8M | $6.5M | +523.94% |
| Q1 2023 | 2023-03-31 | $3.1M | −$906,000 | −22.90% |
| Q4 2022 | 2022-12-31 | $2.0M | — | — |
| Q3 2022 | 2022-09-30 | $2.7M | $768,000 | +39.08% |
| Q2 2022 | 2022-06-30 | $1.2M | −$9.7M | −88.63% |
| Q1 2022 | 2022-03-31 | $4.0M | — | — |
| Q3 2021 | 2021-09-30 | $2.0M | — | — |
| Q2 2021 | 2021-06-30 | $11.0M | — | — |
| Q3 2019 | 2019-09-30 | $10.5M | — | — |
Zevra Therapeutics gross profit trends
Between the periods ended 2018-12-31 and 2025-12-31, Zevra Therapeutics's gross profit increased from $0 to $90.0M, a change of $90.0M. The latest reported quarter, Q2 2026, shows $38.1M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zevra Therapeutics source filings ↗